Your browser version may not work well with NCBI's Web applications. More information here...
1: Cancer Res. 1996 Sep 15;56(18):4124-9.Click here to read Links

A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.

Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama S, Kuwano M.

Department of Biochemistry, Kyushu University School of Medicine, Fukuoka, Japan.

By targeting the ATP binding conserved domain in three ATP binding cassette superfamily proteins (P-glycoprotein, multidrug resistance protein, and cystic fibrosis transmembrane regulator), we isolated the cDNA of a new ATP binding cassette superfamily that was specifically enhanced in a cisplatin-resistant human head and neck cancer KB cell line. A human clone homologous to rat canalicular multispecific organic anion transporter (cMOAT) was found and designated human cMOAT. Fluorescence in situ hybridization demonstrated the chromosomal locus of the gene on chromosome 10q24. The human cMOAT cDNA hybridized a 6.5-kb mRNA that was expressed 4- to 6-fold higher by three cisplatin-resistant cell lines derived from various human tumors exhibiting decreased drug accumulation. Human cMOAT may function as a cellular cisplatin transporter.

PMID: 8797578 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Cisplatin (Platinol®-AQ)

    Your doctor has ordered the drug cisplatin to help treat your illness. The drug is given by injection into a vein.

  • Source: AHFS Consumer Medication Information